Your session is about to expire
← Back to Search
Procedure
Sphenopalatine Ganglion Block for Post-Dural Puncture Headache
Phase 3
Waitlist Available
Led By William Grubb, DDS, MD
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up prior to initiation of therapy (epidural blood patch vs sphenopalatine ganglion block).
Awards & highlights
Study Summary
This trial will compare a pain block in the midface to the traditional, more invasive, therapeutic epidural patch for the treatment of headaches.
Eligible Conditions
- Post-Dural Puncture Headache
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 60 minutes following either therapy.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 60 minutes following either therapy.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of Headaches With a VAS Score >8/10 Prior to Initiation of Either Therapy
Number of Participants With a Headache Vas 8/10 at 30 Minutes Following Either Therapy.
Number of Participants With a Headache Vas 8/10 at 60 Minutes Following Either Therapy.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Sphenopalatine Ganglion BlockExperimental Treatment1 Intervention
Cotton tip applicators are used to deliver lidocaine to the posterior nares in the area of skin overlying the Sphenopalatine gangion
Group II: Epidural blood patchActive Control1 Intervention
20ml of sterile blood is obtained from the patients arm and placed in the epidural space using standard sterile epidural access.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sphenopalatine Ganglion Block
2023
N/A
~50
Find a Location
Who is running the clinical trial?
Rutgers, The State University of New JerseyLead Sponsor
429 Previous Clinical Trials
64,224 Total Patients Enrolled
New Jersey Medical SchoolOTHER
7 Previous Clinical Trials
11,122 Total Patients Enrolled
William Grubb, DDS, MDPrincipal InvestigatorRutgers Robert Wood Johnson Medical School
1 Previous Clinical Trials
8 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger